Quantum BioPharma Statistics
Total Valuation
QNTM has a market cap or net worth of $24.37 million. The enterprise value is $18.75 million.
| Market Cap | 24.37M |
| Enterprise Value | 18.75M |
Important Dates
The next estimated earnings date is Thursday, August 6, 2026, before market open.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
QNTM has 6.40 million shares outstanding. The number of shares has increased by 136.38% in one year.
| Current Share Class | 6.40M |
| Shares Outstanding | 6.40M |
| Shares Change (YoY) | +136.38% |
| Shares Change (QoQ) | +17.16% |
| Owned by Insiders (%) | 7.29% |
| Owned by Institutions (%) | 9.95% |
| Float | 5.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.63
| Current Ratio | 0.63 |
| Quick Ratio | 0.29 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.25 |
Financial Efficiency
Return on equity (ROE) is -2,056.51% and return on invested capital (ROIC) is -353.44%.
| Return on Equity (ROE) | -2,056.51% |
| Return on Assets (ROA) | -62.38% |
| Return on Invested Capital (ROIC) | -353.44% |
| Return on Capital Employed (ROCE) | 1,047.35% |
| Weighted Average Cost of Capital (WACC) | 11.86% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.83M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.23% in the last 52 weeks. The beta is 0.40, so QNTM's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | -85.23% |
| 50-Day Moving Average | 4.93 |
| 200-Day Moving Average | 7.85 |
| Relative Strength Index (RSI) | 38.87 |
| Average Volume (20 Days) | 439,617 |
Short Selling Information
The latest short interest is 411,604, so 6.43% of the outstanding shares have been sold short.
| Short Interest | 411,604 |
| Short Previous Month | 221,665 |
| Short % of Shares Out | 6.43% |
| Short % of Float | 6.94% |
| Short Ratio (days to cover) | 0.93 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.87M |
| Pretax Income | -31.97M |
| Net Income | -31.16M |
| EBITDA | -14.33M |
| EBIT | -14.87M |
| Earnings Per Share (EPS) | -$8.22 |
Balance Sheet
The company has $4.56 million in cash and $870,057 in debt, with a net cash position of $3.69 million or $0.58 per share.
| Cash & Cash Equivalents | 4.56M |
| Total Debt | 870,057 |
| Net Cash | 3.69M |
| Net Cash Per Share | $0.58 |
| Equity (Book Value) | -1.42M |
| Book Value Per Share | 0.10 |
| Working Capital | -5.98M |
Cash Flow
| Operating Cash Flow | -5.64M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 543,526 |
| Net Borrowing | 2.37M |
| Free Cash Flow | -5.64M |
| FCF Per Share | -$0.88 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
QNTM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -136.38% |
| Shareholder Yield | -136.38% |
| Earnings Yield | -127.85% |
| FCF Yield | -23.16% |
Analyst Forecast
The average price target for QNTM is $12.47, which is 228.16% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.47 |
| Price Target Difference | 228.16% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 15, 2024. It was a reverse split with a ratio of 1:65.
| Last Split Date | Aug 15, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:65 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |